Amylyx Pharmaceuticals, Inc. (AMLX) is listed on NASDAQ in Pharmaceutical Stocks. It is $34.78, -6.46%, with a $3.9B market cap. RSI is 68.0, near overbought. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 68.0 Near Overbought
Market Cap $3.9B
Volume 1.2M
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-84.7M
EPS $-0.76
P/E Ratio -45.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Mazzariello Gina | Chief Legal Officer | Sell | 30,000 | $17.96 | $538,868 | 2026 Jul 10 |
| Firestone Karen | Insider | Buy | 3,800 | $13.51 | $51,338 | 2026 May 21 |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 29,282 | $14.47 | $423,760 | 2026 Mar 2 |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 29,282 | $14.48 | $424,120 | 2026 Mar 2 |
| Bedrosian Camille L | Chief Medical Officer | Sell | 6,461 | $14.58 | $94,205 | 2026 Mar 2 |
| Frates James M | Chief Financial Officer | Sell | 7,909 | $14.52 | $114,851 | 2026 Mar 2 |
| Mazzariello Gina | Chief Legal Officer | Sell | 6,844 | $14.52 | $99,378 | 2026 Mar 2 |
| Mazzariello Gina | Chief Legal Officer | Sell | 3,419 | $14.14 | $48,352 | 2026 Feb 23 |
| Firestone Karen | Director | Buy | 8,100 | $12.45 | $100,845 | 2025 Dec 23 |
| Bedrosian Camille L | Chief Medical Officer | Sell | 6,580 | $14.35 | $94,423 | 2025 Dec 1 |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 29,933 | $14.34 | $429,371 | 2025 Sep 30 |
| Bedrosian Camille L | Chief Medical Officer | Sell | 12,039 | $14.58 | $175,529 | 2025 Sep 30 |
| Mazzariello Gina | Chief Legal Officer | Sell | 8,828 | $14.58 | $128,712 | 2025 Sep 30 |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 29,975 | $14.37 | $430,869 | 2025 Sep 30 |
| Frates James M | Chief Financial Officer | Sell | 10,558 | $14.65 | $154,675 | 2025 Sep 30 |
| Mazzariello Gina | Chief Legal Officer | Sell | 30,000 | $8.21 | $246,150 | 2025 Aug 13 |
| Frates James M | Chief Financial Officer | Sell | 10,896 | $3.47 | $37,809 | 2025 Mar 31 |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 21,490 | $3.46 | $74,355 | 2025 Mar 31 |
| Bedrosian Camille L | Chief Medical Officer | Sell | 12,425 | $3.47 | $43,115 | 2025 Mar 31 |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 21,490 | $3.47 | $74,570 | 2025 Mar 31 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $13.71 | 51.0 | $10.9B |
| | $32.15 | 38.6 | $3.8B |
| | $53.91 | 53.0 | $8.3B |
| | $84.95 | 54.8 | $12.0B |
| | $105.79 | 46.8 | $5.9B |
Take AMLX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put AMLX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Amylyx Pharmaceuticals, Inc. next reports.
Set alerts on AMLX
Get notified when Amylyx Pharmaceuticals, Inc. hits your price targets or technical conditions are met.
Get Started Free